PRTA
PRTA

Prothena Corp Plc

NASDAQ · Biotechnology
$8.91
+0.56 (+6.71%)
Analyst Consensus
Buy
13 analysts
Buy 9 69%
Hold 3 23%
Sell 1 8%
Price Target
Analyst Price Target +51.7% upside
Low Target $9.22
Average Target $13.52
High Target $14.31
Current Price $8.91
Current
$8.91
Target
$13.52
$9.22 $13.52 avg $14.31